Advertisement
Screener

INSULET CORPORATION (PODD) Executive Pay versus Performance: Pay versus Performance

INSULET CORPORATION Pay versus Performance

The Pay versus Performance table from each proxy statement (Item 402(v)), as tagged in its XBRL, newest proxy first. Each proxy's own figures are kept, so a year restated in a later proxy appears once per proxy. PEO is the principal executive officer; NEO means the other named executive officers (average). Total shareholder return is the value of a $100 investment.

  • 2025-12-31: PEO Ashley McEvoy; Other NEO average total compensation $3.81M.
  • 2024-12-31: PEO James Hollingshead; Other NEO average total compensation $3.34M.
  • 2023-12-31: PEO James Hollingshead; Other NEO average total compensation $2.84M.
  • 2022-12-31: PEO James Hollingshead; Other NEO average total compensation $3.38M.
Fiscal year endPEOPEO total compensationPEO compensation actually paidOther NEO average total compensationOther NEO average compensation actually paidTotal shareholder returnPeer group total shareholder returnNet incomeCompany-selected measureProxy filed
2025-12-31Ashley McEvoy$3.81M$3.86M$111.19$99.39$247.10MAdjusted revenue
$2.66B
2026-04-06
2024-12-31James Hollingshead$3.34M$6.55M$102.13$81.07$418.30M$2.07B2026-04-06
2023-12-31James Hollingshead$2.84M$351.21K$84.88$81.77$206.30M$1.69B2026-04-06
2022-12-31James Hollingshead$3.38M$4.24M$115.16$76.75$4.60M$1.33B2026-04-06
2021-12-31Shacey Petrovic$2.59M$2.61M$104.08$96.45$16.80M$1.09B2026-04-06
2024-12-31James Hollingshead$13.30M$32.71M$3.34M$6.55M$152.49$105.42$418.30MAdjusted revenue
$2.07B
2025-04-29
2023-12-31James Hollingshead$12.38M$12.80M$2.84M$351.21K$126.74$106.34$206.30M$1.69B2025-04-29
2022-12-31James Hollingshead$3.38M$4.24M$171.96$99.81$4.60M$1.33B2025-04-29
2021-12-31Shacey Petrovic$9.72M$9.12M$2.59M$2.61M$155.41$125.43$16.80M$1.09B2025-04-29
2020-12-31Shacey Petrovic$7.28M$18.86M$2.36M$5.37M$149.32$130.04$6.80M$897.00M2025-04-29
2023-12-31James Hollingshead$12.38M$12.80M$2.84M$351.21K$126.74$106.34$206.30MAdjusted revenue
$1.69B
2024-04-09
2022-12-31James Hollingshead$10.82M$16.06M$3.38M$4.24M$171.96$99.81$4.60M$1.33B2024-04-09
2021-12-31$0.00$0.00$2.59M$2.61M$155.41$125.43$16.80M$1.09B2024-04-09
2020-12-31$0.00$0.00$2.36M$5.37M$149.32$130.04$6.80M$897.00M2024-04-09
2022-12-31James Hollingshead$3.38M$4.24M$171.96$99.81$4.60MAdjusted revenue
$1.33B
2023-04-06
2021-12-31Shacey Petrovic$2.59M$2.61M$155.41$125.43$16.80M$1.09B2023-04-06
2020-12-31Shacey Petrovic$2.36M$5.37M$149.32$130.04$6.80M$897.00M2023-04-06

Similar stocks

Stock NameCountryMarket CapPE Ratio
GLAUKOS Corp (GKOS)United States$9.135B-43.73
GLOBUS MEDICAL INC (GMED)United States$9.977B20.03
BAXTER INTERNATIONAL INC (BAX)United States$12.139B-10.35
Penumbra Inc (PEN)United States$12.596B77.33
MiniMed Group, Inc. (MMED)United States$5.748B-16.85
MERIT MEDICAL SYSTEMS INC (MMSI)United States$5.212B28.44
TELEFLEX INC (TFX)United States$5.093B-5.44
HAEMONETICS CORP (HAE)United States$4.821B36.52
Heartflow, Inc. (HTFL)United States$4.225B
ICU MEDICAL INC/DE (ICUI)United States$4.153B18.85